• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝样细胞的诱导与成熟:聚焦技术进展与挑战

Induction and Maturation of Hepatocyte-Like Cells : Focus on Technological Advances and Challenges.

作者信息

Xie Ye, Yao Jia, Jin Weilin, Ren Longfei, Li Xun

机构信息

The First Clinical Medical College, Lanzhou University, Lanzhou, China.

Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, China.

出版信息

Front Cell Dev Biol. 2021 Nov 26;9:765980. doi: 10.3389/fcell.2021.765980. eCollection 2021.

DOI:10.3389/fcell.2021.765980
PMID:34901010
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8662991/
Abstract

Limited by the poor proliferation and restricted sources of adult hepatocytes, there is an urgent need to find substitutes for proliferation and cultivation of mature hepatocytes for use in disease treatment, drug approval, and toxicity testing. Hepatocyte-like cells (HLCs), which originate from undifferentiated stem cells or modified adult cells, are considered good candidates because of their advantages in terms of cell source and expansion ability. However, the majority of induced HLCs are in an immature state, and their degree of differentiation is heterogeneous, diminishing their usability in basic research and limiting their clinical application. Therefore, various methods have been developed to promote the maturation of HLCs, including chemical approaches, alteration of cell culture systems, and genetic manipulation, to meet the needs of transplantation and model establishment. This review proposes different cell types for the induction of HLCs, and provide a comprehensive overview of various techniques to promote the generation and maturation of HLCs .

摘要

由于成人肝细胞增殖能力差且来源有限,迫切需要寻找用于疾病治疗、药物审批和毒性测试的成熟肝细胞增殖与培养替代品。源自未分化干细胞或经过修饰的成体细胞的肝样细胞(HLCs),因其在细胞来源和扩增能力方面的优势而被视为良好的候选者。然而,大多数诱导生成的HLCs处于未成熟状态,其分化程度存在异质性,这降低了它们在基础研究中的可用性,并限制了其临床应用。因此,人们开发了各种方法来促进HLCs的成熟,包括化学方法、改变细胞培养系统和基因操作,以满足移植和模型建立的需求。本综述提出了用于诱导HLCs的不同细胞类型,并全面概述了促进HLCs生成和成熟的各种技术。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/4c85dca76291/fcell-09-765980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/847aeb168015/fcell-09-765980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/640a65fd4ecb/fcell-09-765980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/a279143c8868/fcell-09-765980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/4c85dca76291/fcell-09-765980-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/847aeb168015/fcell-09-765980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/640a65fd4ecb/fcell-09-765980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/a279143c8868/fcell-09-765980-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db74/8662991/4c85dca76291/fcell-09-765980-g004.jpg

相似文献

1
Induction and Maturation of Hepatocyte-Like Cells : Focus on Technological Advances and Challenges.肝样细胞的诱导与成熟:聚焦技术进展与挑战
Front Cell Dev Biol. 2021 Nov 26;9:765980. doi: 10.3389/fcell.2021.765980. eCollection 2021.
2
Derivation and applications of human hepatocyte-like cells.人肝细胞样细胞的衍生与应用。
World J Stem Cells. 2019 Aug 26;11(8):535-547. doi: 10.4252/wjsc.v11.i8.535.
3
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.从人诱导多能干细胞分化而来的类肝细胞:与细胞治疗的相关性。
Stem Cell Res. 2012 Nov;9(3):196-207. doi: 10.1016/j.scr.2012.06.004. Epub 2012 Jun 28.
4
Generated Hepatocyte-Like Cells: A Novel Tool in Regenerative Medicine and Drug Discovery.生成的类肝细胞:再生医学与药物发现中的一种新型工具。
Cell J. 2017 Jul-Sep;19(2):204-217. doi: 10.22074/cellj.2016.4362. Epub 2017 Feb 22.
5
A robust model of natural hepatitis C infection using hepatocyte-like cells derived from human induced pluripotent stem cells as a long-term host.一种使用源自人类诱导多能干细胞的类肝细胞作为长期宿主的自然丙型肝炎感染的强大模型。
Virol J. 2016 Apr 5;13:59. doi: 10.1186/s12985-016-0519-1.
6
[Generation of Zone-specific Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells for Accurate Prediction of Drug-induced Hepatotoxicity].[从人诱导多能干细胞生成区域特异性肝样细胞以准确预测药物性肝毒性]
Yakugaku Zasshi. 2019;139(12):1509-1512. doi: 10.1248/yakushi.19-00170.
7
[Research advances in hepatocyte-like cells from human induced pluripotent stem cells and their application].人诱导多能干细胞来源的肝样细胞研究进展及其应用
Zhonghua Gan Zang Bing Za Zhi. 2018 Jan 20;26(1):69-72. doi: 10.3760/cma.j.issn.1007-3418.2018.01.016.
8
Current status of hepatocyte-like cell therapy from stem cells.干细胞来源的肝细胞样细胞治疗的现状。
Surg Today. 2021 Mar;51(3):340-349. doi: 10.1007/s00595-020-02092-6. Epub 2020 Aug 4.
9
Hepatocyte-like cells derived from human amniotic epithelial, bone marrow, and adipose stromal cells display enhanced functionality when cultured on decellularized liver substrate.源自人羊膜上皮细胞、骨髓细胞和脂肪基质细胞的类肝细胞,在脱细胞肝脏基质上培养时,其功能会增强。
Stem Cell Res. 2019 Jul;38:101471. doi: 10.1016/j.scr.2019.101471. Epub 2019 May 29.
10
Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions.人干细胞衍生的肝细胞作为乙型肝炎病毒感染、传播及病毒-宿主相互作用的模型。
J Hepatol. 2017 Mar;66(3):494-503. doi: 10.1016/j.jhep.2016.10.009. Epub 2016 Oct 14.

引用本文的文献

1
Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A Review.用于疾病建模和胰岛素抵抗治疗中胰岛素靶细胞再生的人诱导多能干细胞(iPSC):综述
Cells. 2025 Aug 1;14(15):1188. doi: 10.3390/cells14151188.
2
Producing Human Livers From Human Stem Cells Via Blastocyst Complementation.通过囊胚互补从人类干细胞生成人类肝脏。
Curr Opin Biomed Eng. 2024 Sep;31. doi: 10.1016/j.cobme.2024.100537. Epub 2024 May 16.
3
Functional mouse hepatocytes derived from interspecies chimeric livers effectively mitigate chronic liver fibrosis.

本文引用的文献

1
Liver Organoids: Recent Developments, Limitations and Potential.肝脏类器官:最新进展、局限性与潜力
Front Med (Lausanne). 2021 May 5;8:574047. doi: 10.3389/fmed.2021.574047. eCollection 2021.
2
Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia.基于患者特异性诱导多能干细胞衍生的肝细胞样细胞的常染色体隐性遗传性高胆固醇血症模型研究。
Stem Cells Dev. 2021 Jul 15;30(14):714-724. doi: 10.1089/scd.2020.0199. Epub 2021 Jun 8.
3
Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet?
来源于种间嵌合体肝脏的功能性小鼠肝细胞可有效减轻慢性肝纤维化。
Stem Cell Reports. 2024 Jun 11;19(6):877-889. doi: 10.1016/j.stemcr.2024.04.006. Epub 2024 May 9.
4
iPSC-derived cells for whole liver bioengineering.用于全肝生物工程的诱导多能干细胞衍生细胞。
Front Bioeng Biotechnol. 2024 Feb 7;12:1338762. doi: 10.3389/fbioe.2024.1338762. eCollection 2024.
5
A general fluorescence off/on strategy for fluorogenic probes: Steric repulsion-induced twisted intramolecular charge transfer (sr-TICT).一种通用的荧光开启/关闭策略用于荧光探针:空间位阻诱导的扭曲分子内电荷转移(sr-TICT)。
Sci Adv. 2024 Feb 16;10(7):eadi8847. doi: 10.1126/sciadv.adi8847.
6
Insight to Biofabrication of Liver Microtissues for Disease Modeling: Challenges and Opportunities.肝脏微组织的生物制造用于疾病建模的研究进展:挑战与机遇
Curr Stem Cell Res Ther. 2024;19(10):1303-1311. doi: 10.2174/011574888X257744231009071810.
7
LIGHT (TNFSF14) promotes the differentiation of human bone marrow-derived mesenchymal stem cells into functional hepatocyte-like cells.LIGHT(TNFSF14)可促进人骨髓间充质干细胞向功能性肝细胞样细胞分化。
PLoS One. 2023 Aug 8;18(8):e0289798. doi: 10.1371/journal.pone.0289798. eCollection 2023.
8
Human induced pluripotent stem cell-derived liver-on-a-chip for studying drug metabolism: the challenge of the cytochrome P450 family.用于研究药物代谢的人诱导多能干细胞衍生的芯片肝:细胞色素P450家族的挑战。
Front Pharmacol. 2023 Jun 28;14:1223108. doi: 10.3389/fphar.2023.1223108. eCollection 2023.
9
Using liver models generated from human-induced pluripotent stem cells (iPSCs) for evaluating chemical-induced modifications and disease across liver developmental stages.利用人诱导多能干细胞(iPSC)生成的肝脏模型,评估化学诱导修饰物和肝脏发育阶段的疾病。
Toxicol In Vitro. 2022 Sep;83:105412. doi: 10.1016/j.tiv.2022.105412. Epub 2022 Jun 7.
10
Phenotypical, functional and transcriptomic comparison of two modified methods of hepatocyte differentiation from human induced pluripotent stem cells.两种从人诱导多能干细胞诱导肝细胞分化的改良方法的表型、功能和转录组学比较
Biomed Rep. 2022 May;16(5):43. doi: 10.3892/br.2022.1526. Epub 2022 Mar 23.
肝胆类器官及其在肝脏健康和疾病研究中的应用:我们做到了吗?
Hepatology. 2021 Oct;74(4):2251-2263. doi: 10.1002/hep.31772. Epub 2021 May 28.
4
Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes.人多能干细胞向肝细胞分化的先进技术和预期临床应用。
Hepatology. 2021 Aug;74(2):1101-1116. doi: 10.1002/hep.31705. Epub 2021 Aug 22.
5
Fundamental Technologies and Recent Advances of Cell-Sheet-Based Tissue Engineering.基于细胞片层的组织工程的基本技术和最新进展。
Int J Mol Sci. 2021 Jan 3;22(1):425. doi: 10.3390/ijms22010425.
6
Generation of uniform liver spheroids from human pluripotent stem cells for imaging-based drug toxicity analysis.从人多能干细胞生成均一的肝球体用于基于成像的药物毒性分析。
Biomaterials. 2021 Feb;269:120529. doi: 10.1016/j.biomaterials.2020.120529. Epub 2020 Nov 19.
7
Differentiation of induced pluripotent stem cells to hepatocyte-like cells on cellulose nanofibril substrate.诱导多能干细胞在纤维素纳米纤维基底上向肝样细胞的分化。
Colloids Surf B Biointerfaces. 2021 Feb;198:111466. doi: 10.1016/j.colsurfb.2020.111466. Epub 2020 Nov 12.
8
Safety Considerations in 3D Bioprinting Using Mesenchymal Stromal Cells.使用间充质基质细胞进行3D生物打印的安全考量
Front Bioeng Biotechnol. 2020 Oct 8;8:924. doi: 10.3389/fbioe.2020.00924. eCollection 2020.
9
Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model.人诱导多能干细胞衍生肝类器官移植到猪模型婴幼儿患者的临床安全性研究。
Cell Transplant. 2020 Jan-Dec;29:963689720964384. doi: 10.1177/0963689720964384.
10
High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.使用人多能干细胞衍生类器官进行高逼真度药物性肝损伤筛选。
Gastroenterology. 2021 Feb;160(3):831-846.e10. doi: 10.1053/j.gastro.2020.10.002. Epub 2020 Oct 8.